5Y Annualised Return
▲7.72%
10Y Annualised Return
▼-1.05%
Vivanza Biosciences Stock Performance
|
|
|
Vivanza Biosciences Company background
Founded in: 1982
Managing director: Jayendra Mehta
Vivanza Biosciences Limited(Previously known Ivee Injectaa Limited) was established in March, 1982 as a Private Limited Company and was converted into a Public Limited Company in May, 1992. Due to recessionary trends which lead to difficult business conditions in the year 19992000, the parenteral industry suffered a setback. As a result of this, the name of the Company was changed from Ivee Injectaa Limited to Vivanza Biosciences Limited in 2015.The Company is focused in commercializing novel and generic pharmaceuticals, offering patients better, safe and more accessible medicines. It is presently engaged in the business of Pharmaceutical Products and Pharma Products.Head quartered in Gujarat, India, Company came into existence in April 2016 to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system. Company undertook an expansioncumdiversification programme to increase its capacity from 18 lac pa to 54 lac pa. It came out with a public issue of 21,70,000 equity shares of Rs 10 each for cash at par aggregating Rs 217 lac. It is one of the few companies which has facilities for both glass as well as plastic containers. The Company acquired 100% Equity Shares of Vivanza Lifesciences Private Limited and by virtue of the holding in Vivanza Lifesciences Private Limited it became Wholly Owned Subsidiary w.e.f. 17 June, 2016.
Vivanza Biosciences Financial Highlights
Vivanza Biosciences reported a Q2 FY2025–2026 revenue of ₹8.94 crore, down -73.2% YoY, with net profit decreased -221.8% to ₹0.09 crore. For the full year FY2025–2026, revenue reached ₹7.48 crore and profit touched at ₹-0.67 crore. As of Jun '25, Vivanza Biosciences’s market capitalisation stood at ₹8.60 crores. Shareholding as of Jun '25 shows promoters holding 20%, with FIIs at 80%, DIIs at %, and public at %.
As of 20 Aug, 2025, Vivanza Biosciences share price is ₹2.1. The stock opened at ₹2.1 and had closed at ₹2.2 the previous day. During today’s trading session, Vivanza Biosciences share price moved between ₹2.06 and ₹2.11, with an average price for the day of ₹2.08. Over the last 52 weeks, the stock has recorded a low of ₹1.90 and a high of ₹4.90. In terms of performance, Vivanza Biosciences share price has declined by 26.1% over the past six months and has declined by 50.36% over the last year.
Vivanza Biosciences SIP Return Calculator
Over the past
5 years
Total Investment of ₹3,25,00,000
Would have become ₹3,96,68,543 (+22.06%)
Daily SIP of ₹25,000 would have become ₹3,96,68,543 in 5 years with a gain of ₹71,68,543 (+22.06%)
Vivanza Biosciences Fundamental
Market Cap (in crs)
8.60
Face Value
1
Turnover (in lacs)
3.33
Key Metrics
Qtr Change %
57.76% Fall from 52W High
-18.5
Dividend yield 1yr %
0
Vivanza Biosciences Key Financials
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Vivanza Biosciences Quarterly Revenue
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
8.94 Cr | 0.48 Cr | 1.5 Cr | 3 Cr | 2.44 Cr |
Vivanza Biosciences Yearly Revenue
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
7.48 Cr | 27.89 Cr | 18.28 Cr | 11.23 Cr | 10.39 Cr | 10.19 Cr |
Vivanza Biosciences Quarterly Net Profit/Loss
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
0.09 Cr | -1 Cr | 0.04 Cr | 0.02 Cr | 0.27 Cr |
Vivanza Biosciences Yearly Net Profit/Loss
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
-0.67 Cr | 0.55 Cr | 0.6 Cr | 0.33 Cr | 0.08 Cr | -0.21 Cr |
Vivanza Biosciences Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
2.07
Current Price
5Day EMA
2.10
10Day EMA
2.10
12Day EMA
2.10
20Day EMA
2.10
26Day EMA
2.10
50Day EMA
2.20
100Day EMA
2.30
200Day EMA
2.90
5Day SMA
2.10
10Day SMA
2.10
20Day SMA
2.10
30Day SMA
2.10
50Day SMA
2.10
100Day SMA
2.20
150Day SMA
2.40
200Day SMA
2.70
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 60331 Rs | 60331 Rs |
Week Rs | 40019 Rs | 40019 Rs |
Month Rs | 34890 Rs | 34890 Rs |
Resistance & Support
2.14
Pivot
Resistance
First Resistance
2.19
Second Resistance
2.24
Third Resistance
2.29
Support
First Support
2.09
Second support
2.04
Third Support
1.99
Relative Strength Index
55.63
Money Flow Index
60.41
MACD
-0.01
MACD Signal
-0.02
Average True Range
0.08
Average Directional Index
20.65
Rate of Change (21)
2.38
Rate of Change (125)
-7.33
Vivanza Biosciences Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12.85 | 9.95 | 9.57 | 24.96 | 12.24 | -9.89% | 6.37% | 13.72% | -33.39% | -45.44% | 0.00% | 0.00 | 40.64 | 5.02 | |
18.90 | 5.40 | 15.46 | 26.05 | 18.00 | 10.14% | 1.61% | -10.00% | -2.63% | 9.06% | 0.00% | 0.00 | 40.64 | 1.61 | |
Kobo Biotech Ltd. | 2.50 | 2.50 | - | - | - | - | - | - | - | - | - | - | - | - |
8.23 | 8.44 | 6.7 | 13.47 | 8.23 | -5.29% | -8.86% | -10.54% | 1.60% | 118.30% | 0.00% | 274.33 | 40.64 | 9.37 | |
17.10 | 9.54 | 9.4 | 26.01 | 16.30 | 9.62% | 3.89% | 5.23% | 0.77% | 95.43% | 0.00% | 0.00 | 40.64 | -6.39 | |
3.26 | 8.02 | 2.97 | 15.5 | 3.21 | 0.31% | -13.30% | -15.76% | -73.37% | -78.27% | 0.00% | 0.00 | 40.64 | 0.19 |
Vivanza Biosciences Share Price FAQs
How to buy Vivanza Biosciences shares?
You can easily buy Vivanza Biosciences shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Vivanza Biosciences ?
The 52-week high and low of Vivanza Biosciences share price is ₹4.9 and ₹1.9 as of 20/8/2025.
Please be aware that Vivanza Biosciences stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account